ASO Author Reflections: The Challenging Journey from cCR to pCR After Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma

Ann Surg Oncol. 2024 Feb 16. doi: 10.1245/s10434-024-15035-z. Online ahead of print.

Author

Affiliation

¹ State Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Thoracic Surgery of Department, Peking University Cancer Hospital and Institute, Beijing, 100142, China. chenkeneng@bjmu.edu.cn.

PMID: 38366184
DOI: 10.1245/s10434-024-15035-z

No abstract available

Grants and funding

XXT018/the Beijing Municipal Administration of Hospitals Special Fund for Digestive System Multidisciplinary Synergic Development